2-Deoxy-D-Glucose Covid PDF
Permission for conducting clinical study entitled, “A Randomized, Open Label, 2-Treatment Groups Clinical Trial Evaluating the Safety and Efficacy of 2-Deoxy-D-Glucose as an adjunctive therapy to standard of care, in comparison to standard of care alone, in the Acute Treatment of moderate to severe COVID -19 patients
- Names of the new drug or investigational new drug: 2-Deoxy-D-Glucose (2-DG)
- Therapeutic class: Antimetabolite
- Dosage form: Oral Powders
- Composition: 2- Deoxy-D-Glucose (2-DG), 2/5/10 gram (g) Sachet, Each Sachet contains 2/5/10 gram (g) I.P. Active.
- Indications: Acute Treatment of moderate to severe Covid 19 patients
INFORMATION OF PDF FILE FOR FREE DOWNLOAD | |
Title of PDF File | 2-Deoxy-D-Glucose Covid PDF |
Language of PDF File | English |
Size of PDF File | 239 KB |
No of Pages in PDF File | 5 |